$GTCH "GBT/Tokenize R&D is constantly researching to improve and enhance the technology. As we are geared to release the first version of qTerm medical device soon, our research team is already seeking how to provide more advanced solutions for future releases. We consider qTerm as an evolutionary product that will continue to evolve, include additional features, provide faster results with less power consumption, we are already researching within a few domains in order to improve the product. Our research is focused on improving the device power management system, providing rapid results and creating new methods for data analysis. Another key feature is to keep the device's user friendliness, small size and ease of use. We are going to research methods of PPG (photoplethysmography) also to consider further vitals devices that could provide vitals measurements of any human organ surface. This may lead to the development of further devices of different shapes and characteristics. Since future versions of qTerm are planned to include blood pressure features we are researching new approaches and methods to enable optimal and accurate results. Another aspect is aesthetics, look and feel. We strongly believe that a device of this nature should be easy for use, with long battery life and attractive. As with any aspect of electronic devices, looks play a major role. For example, we all like gadgets and gizmos that simply look cool! It's our job to ensure reliable, accurate results within a 'cool' packaging. Last, but not least, a crucial factor is the product's cost. We keep in mind that the actual cost to the consumer has to be carefully considered. We are facing a constant challenge of providing high quality products that include the most up-to-date electronics, at an affordable cost. We are evaluating larger versions of the device for potential use in hospitals and clinics so we are looking into different enclosure's size and matching product's prices. An efficient R&D team must move forward at all times in order to constantly seek new technological solutions, research and develop better designs with higher performance for the user's benefit," stated Danny Rittman, GBT’s CTO.
Testing Advanced Oxygen & Heart Rate Systems:
Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/Attach...3b06e78b65
https://www.globenewswire.com/NewsRoom/Attach...558b72f7b5
https://www.bloomberg.com/press-releases/2020...te-systems
Testing Advanced Oxygen & Heart Rate Systems:
Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/Attach...3b06e78b65
https://www.globenewswire.com/NewsRoom/Attach...558b72f7b5
https://www.bloomberg.com/press-releases/2020...te-systems
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
